Regional Node Dissection for Melanoma: Techniques and Indication

Surgical Oncology Clinics of North America

Volumn 16, Issue 1, 2007, Pages 247-261

  Jakub, James W ^a   Reintgen, Douglas S ^a   Shivers, Steven ^a   Pendas, Solange ^a  

^a Lakeland Regional Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AXILLARY LYMPH NODE; HUMAN; INGUINAL LYMPH NODE; LYMPH NODE DISSECTION; MELANOMA; NECK DISSECTION; REVIEW; SENTINEL LYMPH NODE; SURGICAL TECHNIQUE; TREATMENT INDICATION;

AXILLA; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MELANOMA; NECK DISSECTION; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; SENTINEL LYMPH NODE BIOPSY; SURVIVAL ANALYSIS;

EID: 33847312222     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2006.10.012     Document Type: Review

References (32)

1. Balch C.M., and Sim F.H. Elective lymph node dissection: results of prospective randomized surgical trials. In: Balch C.M., and Sober A.J. (Eds). Cutaneous melanoma (2003), Quality Medical Publishing Inc, St. Louis (MO) 379-395
2. Balch C.M., Soong S.J., Bartolucci A.A., et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 224 3 (1996) 255-263 [discussion: 263-6]
3. Cascinelli N., Morabito A., Santinami M., et al. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet 351 9105 (1998) 793-796
4. Sim F.H., Taylor W.F., Pritchard D.J., et al. Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study. Mayo Clin Proc 61 9 (1986) 697-705
5. Veronesi U., Adamus J., Bandiera D.C., et al. Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer 49 11 (1982) 2420-2430
6. Lens M.B., Dawes M., Goodacre T., et al. Elective lymph node dissection in patients with melanoma: systematic review and meta-analysis of randomized controlled trials. Arch Surg 137 4 (2002) 458-461
7. Balch C.M., Buzaid A.C., Soong S.J., et al. Final version of the American Joint Committee on cancer staging system for cutaneous melanoma. J Clin Oncol 19 16 (2001) 3635-3648
8. Dessureault S., Soong S.J., Ross M.I., et al. Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy. Ann Surg Oncol 8 10 (2001) 766-770
9. Balch C.M., Soong S., Ross M.I., et al. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup melanoma surgical trial. Ann Surg Oncol 7 2 (2000) 87-97
10. Kretschmer L., Hilgers R., Mohrle M., et al. Patients with lymphatic metastasis of cutaneous malignant melanoma benefit from sentinel lymphnodectomy and early excision of their nodal disease. Eur J Cancer 40 2 (2004) 212-218
11. Essner R., Conforti A., Kelley M.C., et al. Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma. Ann Surg Oncol 6 5 (1999) 442-449
12. Morton DL, Cochran AJ. Interim results of the multicenter selective lymphadenectomy trial (MSLT-1) in clinical stage I melanoma. J Clin Oncol 2005;23(16 Suppl):710-4.
13. Wong S.L., Brady M.S., Busam K.J., et al. Results of sentinel lymph node biopsy in patients with thin melanoma. Ann Surg Oncol 13 3 (2006) 302-309
14. Sondak V.K., Taylor J.M., Sabel M.S., et al. Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model. Ann Surg Oncol 11 3 (2004) 247-258
15. Stitzenberg K.B., Groben P.A., Stern S.L., et al. Indications for lymphatic mapping and sentinel lymphadenectomy in patients with thin melanoma (Breslow thickness < or = 1.0 mm). Ann Surg Oncol 11 10 (2004) 900-906
16. Kesmodel S.B., Karakousis G.C., Botbyl J.D., et al. Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas. Ann Surg Oncol 12 6 (2005) 449-458
17. Puleo C.A., Messina J.L., Riker A.I., et al. Sentinel node biopsy for thin melanomas: which patients should be considered?. Cancer Control 12 4 (2005) 230-235
18. Gershenwald J.E., Colome M.I., Lee J.E., et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 16 6 (1998) 2253-2260
19. Clary B.M., Mann B., Brady M.S., et al. Early recurrence after lymphatic mapping and sentinel node biopsy in patients with primary extremity melanoma: a comparison with elective lymph node dissection. Ann Surg Oncol 8 4 (2001) 328-337
20. Chao C., Wong S.L., Ross M.I., et al. Patterns of early recurrence after sentinel lymph node biopsy for melanoma. Am J Surg 184 6 (2002) 520-524 [discussion: 525]
21. Yee V.S., Thompson J.F., McKinnon J.G., et al. Outcome in 846 cutaneous melanoma patients from a single center after a negative sentinel node biopsy. Ann Surg Oncol 12 6 (2005) 429-439
22. Zogakis T.G., Essner R., Wang H.J., et al. Melanoma recurrence patterns after negative sentinel lymphadenectomy. Arch Surg 140 9 (2005) 865-871 [discussion: 871-2]
23. Sabel M.S., Griffith K., Sondak V.K., et al. Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma. J Am Coll Surg 201 1 (2005) 37-47
24. McMasters K.M., Noyes R.D., Reintgen D.S., et al. Lessons learned from the sunbelt melanoma trial. J Surg Oncol 86 4 (2004) 212-223
25. McMasters K.M., Wong S.L., Edwards M.J., et al. Frequency of nonsentinel lymph node metastasis in melanoma. Ann Surg Oncol 9 2 (2002) 137-141
26. Jakub J., Diaz N., Ebert M., et al. Completion axillary lymph node dissection minimizes the likelihood of false negatives for patients with invasive breast carcinoma and cytokeratin positive only sentinel lymph nodes. Am J Surg 184 4 (2002) 302-305
27. Van Zee K.J., Manasseh D.M., Bevilacqua J.L., et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 10 10 (2003) 1140-1151
28. Joseph E., Brobeil A., Glass F., et al. Results of complete lymph node dissection in 83 melanoma patients with positive sentinel nodes. Ann Surg Oncol 5 2 (1998) 119-125
29. McMasters K., and Tyler D. Axillary and epitrochlear lymph node dissection. In: Balch C.M., and Sober A.J. (Eds). Cutaneous melanoma (2003), Quality Medical Publishing Inc, St. Louis (MO) 397-404
30. Wilke L.G., McCall L.M., Posther K.E., et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol 13 4 (2006) 491-500
31. Beitsch P., and Balch C. Operative morbidity and risk factor assessment in melanoma patients undergoing inguinal lymph node dissection. Am J Surg 164 5 (1992) 462-465 [discussion: 465-6]
32. O'Brien C., and Pathak I. Neck dissection and parotidectomy. In: Balch C.M., and Sober A.J. (Eds). Cutaneous melanoma (2003), Quality Medical Publishing Inc, St. Louis (MO) 419-438